Association of dietary and supplemental iron and colorectal cancer in a population-based study

Joseph H. Ashmore, Samuel M. Lesko, Paige E. Miller, Amanda J. Cross, Joshua E. Muscat, Junjia Zhu, Jason Liao, Gregory Harper, Philip Lazarus, Terryl J. Hartman

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We evaluated the role of dietary iron, heme iron, and supplemental iron on colorectal cancer (CRC) risk in a population-based case-control study in Pennsylvania, including 1005 incident cases and 1062 controls. Diet was assessed through a modified food frequency questionnaire that included supplement use and a meat-specific module. Cases reported intakes for the year before diagnosis, whereas controls reported intakes for the year before interview. Heme iron intake was calculated using a new heme database developed by the US National Cancer Institute. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron intake was inversely associated with CRC among women (OR Q5 vs. Q1=0.45; 95% CI=0.22-0.92), but not among men. Supplemental iron intake of more than 18 mg/day versus none was positively associated with CRC incidence (OR=2.31; 95% CI=1.48-3.59; P-trend<0.001), an effect that was observed in both men (OR=2.56; 95% CI=1.30-5.05) and women (OR=2.46; 95% CI=1.34-4.52). These findings suggest that consumption of more than 18 mg/day of supplemental iron may increase risk for CRC.

Original languageEnglish (US)
Pages (from-to)506-511
Number of pages6
JournalEuropean Journal of Cancer Prevention
Volume22
Issue number6
DOIs
StatePublished - Nov 1 2013

Fingerprint

Dietary Iron
Colorectal Neoplasms
Iron
Heme
Odds Ratio
Confidence Intervals
Population
National Cancer Institute (U.S.)
Incidence
Meat
Case-Control Studies
Logistic Models
Databases
Interviews
Diet
Food

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Ashmore, Joseph H. ; Lesko, Samuel M. ; Miller, Paige E. ; Cross, Amanda J. ; Muscat, Joshua E. ; Zhu, Junjia ; Liao, Jason ; Harper, Gregory ; Lazarus, Philip ; Hartman, Terryl J. / Association of dietary and supplemental iron and colorectal cancer in a population-based study. In: European Journal of Cancer Prevention. 2013 ; Vol. 22, No. 6. pp. 506-511.
@article{ff98fa244801464190ebd0b0aa7130c0,
title = "Association of dietary and supplemental iron and colorectal cancer in a population-based study",
abstract = "We evaluated the role of dietary iron, heme iron, and supplemental iron on colorectal cancer (CRC) risk in a population-based case-control study in Pennsylvania, including 1005 incident cases and 1062 controls. Diet was assessed through a modified food frequency questionnaire that included supplement use and a meat-specific module. Cases reported intakes for the year before diagnosis, whereas controls reported intakes for the year before interview. Heme iron intake was calculated using a new heme database developed by the US National Cancer Institute. Odds ratios (ORs) and 95{\%} confidence intervals (CIs) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron intake was inversely associated with CRC among women (OR Q5 vs. Q1=0.45; 95{\%} CI=0.22-0.92), but not among men. Supplemental iron intake of more than 18 mg/day versus none was positively associated with CRC incidence (OR=2.31; 95{\%} CI=1.48-3.59; P-trend<0.001), an effect that was observed in both men (OR=2.56; 95{\%} CI=1.30-5.05) and women (OR=2.46; 95{\%} CI=1.34-4.52). These findings suggest that consumption of more than 18 mg/day of supplemental iron may increase risk for CRC.",
author = "Ashmore, {Joseph H.} and Lesko, {Samuel M.} and Miller, {Paige E.} and Cross, {Amanda J.} and Muscat, {Joshua E.} and Junjia Zhu and Jason Liao and Gregory Harper and Philip Lazarus and Hartman, {Terryl J.}",
year = "2013",
month = "11",
day = "1",
doi = "10.1097/CEJ.0b013e32836056f8",
language = "English (US)",
volume = "22",
pages = "506--511",
journal = "European Journal of Cancer Prevention",
issn = "0959-8278",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

Association of dietary and supplemental iron and colorectal cancer in a population-based study. / Ashmore, Joseph H.; Lesko, Samuel M.; Miller, Paige E.; Cross, Amanda J.; Muscat, Joshua E.; Zhu, Junjia; Liao, Jason; Harper, Gregory; Lazarus, Philip; Hartman, Terryl J.

In: European Journal of Cancer Prevention, Vol. 22, No. 6, 01.11.2013, p. 506-511.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Association of dietary and supplemental iron and colorectal cancer in a population-based study

AU - Ashmore, Joseph H.

AU - Lesko, Samuel M.

AU - Miller, Paige E.

AU - Cross, Amanda J.

AU - Muscat, Joshua E.

AU - Zhu, Junjia

AU - Liao, Jason

AU - Harper, Gregory

AU - Lazarus, Philip

AU - Hartman, Terryl J.

PY - 2013/11/1

Y1 - 2013/11/1

N2 - We evaluated the role of dietary iron, heme iron, and supplemental iron on colorectal cancer (CRC) risk in a population-based case-control study in Pennsylvania, including 1005 incident cases and 1062 controls. Diet was assessed through a modified food frequency questionnaire that included supplement use and a meat-specific module. Cases reported intakes for the year before diagnosis, whereas controls reported intakes for the year before interview. Heme iron intake was calculated using a new heme database developed by the US National Cancer Institute. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron intake was inversely associated with CRC among women (OR Q5 vs. Q1=0.45; 95% CI=0.22-0.92), but not among men. Supplemental iron intake of more than 18 mg/day versus none was positively associated with CRC incidence (OR=2.31; 95% CI=1.48-3.59; P-trend<0.001), an effect that was observed in both men (OR=2.56; 95% CI=1.30-5.05) and women (OR=2.46; 95% CI=1.34-4.52). These findings suggest that consumption of more than 18 mg/day of supplemental iron may increase risk for CRC.

AB - We evaluated the role of dietary iron, heme iron, and supplemental iron on colorectal cancer (CRC) risk in a population-based case-control study in Pennsylvania, including 1005 incident cases and 1062 controls. Diet was assessed through a modified food frequency questionnaire that included supplement use and a meat-specific module. Cases reported intakes for the year before diagnosis, whereas controls reported intakes for the year before interview. Heme iron intake was calculated using a new heme database developed by the US National Cancer Institute. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron intake was inversely associated with CRC among women (OR Q5 vs. Q1=0.45; 95% CI=0.22-0.92), but not among men. Supplemental iron intake of more than 18 mg/day versus none was positively associated with CRC incidence (OR=2.31; 95% CI=1.48-3.59; P-trend<0.001), an effect that was observed in both men (OR=2.56; 95% CI=1.30-5.05) and women (OR=2.46; 95% CI=1.34-4.52). These findings suggest that consumption of more than 18 mg/day of supplemental iron may increase risk for CRC.

UR - http://www.scopus.com/inward/record.url?scp=84885190614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885190614&partnerID=8YFLogxK

U2 - 10.1097/CEJ.0b013e32836056f8

DO - 10.1097/CEJ.0b013e32836056f8

M3 - Article

C2 - 23492957

AN - SCOPUS:84885190614

VL - 22

SP - 506

EP - 511

JO - European Journal of Cancer Prevention

JF - European Journal of Cancer Prevention

SN - 0959-8278

IS - 6

ER -